PERRY DEBRA J
Known title: DirectorCIK: 0001285092
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Korn Ferry Stock Faces Valuation Questions. Recent reports suggest Korn Ferry shares are trading at a discount relative to their earnings strength, prompting market debate over the company's growth story. The stock is currently near its 52-week low, which may explain why some analysts view the current price as undervalued. With an average analyst target of $90.25, there is a notable gap between the current trading level and professional forecasts.
Transaction History
| AIZN | ▲ Buy | Grant | 881 | $0 | 5/22/2025 | View on chart |
| KFY | ▼ Sell | Open Market | 5,280 | $387K | 10/15/2024 | View on chart |
| KFY | ▲ Buy | Grant | 4,210 | $0 | 9/25/2024 | View on chart |
| AIZN | ▲ Buy | Grant | 947 | $0 | 5/24/2024 | View on chart |
| KFY | ▲ Buy | Grant | 6,410 | $0 | 9/21/2023 | View on chart |
| AIZN | ▲ Buy | Grant | 1,235 | $0 | 5/12/2023 | View on chart |
| KFY | ▲ Buy | Grant | 3,850 | $0 | 9/22/2022 | View on chart |
| AIZN | ▲ Buy | Grant | 881 | $0 | 5/13/2022 | View on chart |
| KFY | ▲ Buy | Grant | 2,050 | $0 | 9/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Analysts Raise AIZN Price Target 13.72% to $19.99
Analysts have raised the consensus price target for Assurant's 2061 subordinated notes by 13.72% to $19.99, suggesting improving sentiment toward the insurer's credit outlook. The notes currently trade near support at $19.09 with an RSI of 28.6, indicating technical oversold conditions. This upward revision in price targets may reflect views that the notes are undervalued at current levels.
Analysts Raise AIZN Price Target 13.72% to $19.99. Analysts have raised the consensus price target for Assurant's 2061 subordinated notes by 13.72% to $19.99, suggesting improving sentiment toward the insurer's credit outlook. The notes currently trade near support at $19.09 with an RSI of 28.6, indicating technical oversold conditions. This upward revision in price targets may reflect views that the notes are undervalued at current levels.